European cohort study.

Boosted REYATAZ shows long lasting viral suppression in women with HIV Bristol-Myers Squibb Business announced outcomes from a long-term, retrospective, European cohort study, including 1,294 antiretroviral -experienced patients from Germany, Sweden and France, today at the 6th International AIDS Society Meeting on HIV Pathogenesis which were presented, Treatment and Avoidance . In a gender-specific sub-evaluation, boosted REYATAZ – -structured regimens demonstrated no difference with time to virologic failing in women in comparison to guys over a follow-up amount of up to five years.

On Thursday EDT, Dec. 2. HIMSS provides accepted the webinar for 1.2 get in touch with hours towards recertification of the Accredited Professional in Healthcare Info and Management Systems credential.. Bottomline expert to go over on disparate systems to get rid of paper in healthcare organizations Bottomline Systems , a respected service provider of collaborative payment, record and invoice automation solutions, today announced it’ll provide insights and tips for healthcare organizations thinking about eliminating paper from their business procedures and saving money and time with a webinar co-sponsored by the Health care Information and Administration Systems Society .